Läkemedelsindustriföreningen

Lif · Trade and business associations · SE

Kategorija
Trade and business associations
Būstinė
Stockholm SE
Registruota
2017-12-05
Deklaruotos metinės išlaidos
50 000–99 999 € (pačios deklaruota)
Svetainė
http://www.lif.se
Skaidrumo registras
544344129150-31 ↗
Susitikimai su EK
Pateiktos pozicijos
0
Pozicijos dokumentai
0
Paminėjimai spaudoje
Sumą deklaruoja pati organizacija Skaidrumo registre; institucijos jos netikrina.

Susitikimai pagal metus

20256202610

Šaltinis: Europos Komisijos skelbiami susitikimai, sutapatinti pagal skaidrumo registro numerį. n = 16 susitikimų; x — metai pagal susitikimo datą, y — susitikimų skaičius.

Susitikimai su Europos Komisija

Skelbiami tik susitikimai su Komisijos nariais, jų kabinetais ir generaliniais direktoriais. Susitikimai žemesniu lygiu ir daugelis kontaktų Parlamente bei Taryboje į registrą nepatenka.
DataPriėmėTema
2026-06-02Cabinet of Commissioner Ekaterina ZaharievaLife sciences
2026-06-02Cabinet of Commissioner Ekaterina ZaharievaLife sciences
2026-06-02Cabinet of Commissioner Ekaterina ZaharievaLife sciences
2026-06-02Cabinet of Commissioner Ekaterina ZaharievaLife sciences
2026-06-02Cabinet of Commissioner Ekaterina ZaharievaLife sciences
2026-06-02Cabinet of Commissioner Ekaterina ZaharievaLife sciences
2026-06-02Cabinet of Commissioner Ekaterina ZaharievaLife sciences
2026-06-02Cabinet of Commissioner Ekaterina ZaharievaLife sciences
2026-06-02Cabinet of Commissioner Ekaterina ZaharievaLife sciences
2026-06-02Cabinet of Commissioner Ekaterina ZaharievaLife sciences
2025-03-15Cabinet of Commissioner Jessika RoswallImpact of EU environmental policies on the life science sector
2025-03-15Cabinet of Commissioner Jessika RoswallImpact of EU environmental policies on the life science sector
2025-02-11Internal Market, Industry, Entrepreneurship and SMEsThe current state of the EU pharmaceutical sector, ways to strengthen EU competitiveness, the forthcoming Life Sciences Strategy and Biotech Act
2025-02-11Health and Food SafetyExchange of views on EU policies in the areas of life science and biotechnology
2025-02-11Health and Food SafetyExchange of views on EU policies in the areas of life science and biotechnology
2025-02-11Internal Market, Industry, Entrepreneurship and SMEsThe current state of the EU pharmaceutical sector, ways to strengthen EU competitiveness, the forthcoming Life Sciences Strategy and Biotech Act

Ką pateikė viešoms konsultacijoms

2025-09-10 · Simplification of administrative burdens in environmental legislation ↗ originalus šaltinis
Lif the research-based pharmaceuticals industry in Sweden is grateful for the opportunity to give our remarks on the proposal. The life sciences sectorcovering pharmaceuticals, medical devices, in vitro diagnostics, medical software, and biotechnologyis a strategic industry for Sweden. Employing over 52,000 people, it accounts for 10% of the countrys total goods exports. Swedish and European companies in this sector invest heavily in research and development, fuelling advances in biotechnology, AI, and digital health and continuously strive to reduce the environmental impact from the industry and its products. The pharmaceutical industry is driving for sustainability through new and more…

Kokias ES temas nurodo sekanti

Biotech Act
EU Life sciences strategy
REACH
UWWTD
EU Pharma legislation
EU Patent Package
EHDS
AI ACT
EU Pharmaceutical Incentives Analysis.
EU HTA Regulation
IHI
AMR
Pharmacueticals in the environment (PiE)